<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02607345</url>
  </required_header>
  <id_info>
    <org_study_id>2015/030</org_study_id>
    <nct_id>NCT02607345</nct_id>
  </id_info>
  <brief_title>25gr. Glucomedics vs 25gr. Zusto</brief_title>
  <official_title>25gr. Glucomedics vs 25gr. Zusto</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bart Keymeulen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AZ-VUB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: to compare blood glucose and insulin responses after consumption of 100ml water,
      sweetened with 25gr Zusto® and 100ml water sweetened with 25gr Glucomedics® (standard drink)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an experimental study enrolling 10 healthy female subjects. The study compares the
      blood glucose and insulin responses after consumption of 100ml water, sweetened with 25gr
      Zusto® and 100ml water sweetened with 25gr Glucomedics® (standard drink). Subjects need to be
      fasted for at least 8 hours before all visits. At visit 1, five women will consume the
      solution with 25gr Zusto®, the other five will have the solution with 25gr Glucomedics®. On
      visit 2, groups will be switched. Visit 1 and 2 will be performed within approximately one
      week interval.

      Both drinks will be identical in amount of water and only be different by the use of 25gr
      Glucomedics® and 25gr Zusto®.

      Before intake of the drink, vital signs, weight and bedside blood glucose and baseline blood
      samples - 15' and 0' for glucose, insulin and C-peptide will be taken at visit 1 and 2. Both
      drinks will be consumed within 5 minutes and time of start and end of intake of Zusto® /
      Glucomedics® will be documented.

      Blood samples for glucose, insulin and C-peptide will be taken at 15', 30', 60', 90', 120'
      and 180' after start of intake 25gr Zusto® and 25gr Glucomedics®.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the difference in glycemic index between 25gr. Zusto® and 25gr. Glucomedics®</measure>
    <time_frame>1 month</time_frame>
    <description>GI values will be calculated using the iAUC of Zusto® intake and Glucomedics® intake.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Glucomedics®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25gr Glucomedics®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Zusto®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>25gr Zusto®</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Zusto</intervention_name>
    <description>25gr</description>
    <arm_group_label>Zusto®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Glucomedics®</intervention_name>
    <description>25gr</description>
    <arm_group_label>Glucomedics®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female subjects

          -  Age between 30 and 50 years

          -  BMI between 20 and 30 kg/m²

        Exclusion Criteria:

          -  No first degree relatives with mellitus type 1 or type 2

          -  No intake of medication with influence blood glucose levels

          -  Pregnant, breast feeding or planning to become pregnant during the study

          -  Employer of the investigator or study center with direct involvement in the proposed
             study or other studies under the direction of the investigator or study center
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bart Keymeulen, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2015</study_first_submitted>
  <study_first_submitted_qc>November 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2015</study_first_posted>
  <last_update_submitted>November 16, 2015</last_update_submitted>
  <last_update_submitted_qc>November 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>AZ-VUB</investigator_affiliation>
    <investigator_full_name>Bart Keymeulen</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

